ImmunoGen Reports Recent Progress and First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. PLTR
4. LITE
5. REGN
6. ABBV
7. MRVL
8. CL
9. CHKP
10. LYB

Go back to ImmunoGen Reports Recent Progress and First Quarter 2019 Financial Results

Immunogen (IMGN) Misses Q1 EPS by 10c

May 3, 2019 6:33 AM EDT

Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.30), $0.10 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $10.59 million.

For earnings history and earnings-related data on Immunogen (IMGN) click here.

... More